TM Editors' Note: This article discusses a microcap and/or penny stock. Such stocks are easily manipulated; do your own careful due diligence.

Shares of Sientra (SIEN) suffered a disastrous 2015 after its Brazil-based contract manufacturer, Silimed, had its CE Mark for making medical devices suspended by the UK and Brazil, effectively pausing the sale of Sientra's products. In addition, the company completed an equity raise, and a fire roared through Silimed's main building where Sientra products are produced...tough break.

After being up more than 50% for the year in September, shares took a nosedive on the news and finished 2015 down 64%.

From peak to trough, Sientra lost nearly $400M in market capitalization in a mere two months.

Going into 2016, shares of Sientra look poised to go into rally mode and regain some lost ground.

Fundamentally, the company replaced its Chairman and CEO and is working with its supplier in Brazil to restart production of its products, and diversify its supplier base. Make no mistake, the production halt is temporary and will be resolved. New management can quickly right this ship. Impatient investors sold Sientra to the ground, but often, investor impatience creates opportunity for medium/long term investors. This seems to be the case for Sientra.

Technically, shares of Sientra are showing positive signs. To continue reading, click here.